Journal article
Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets
DK Lau, D Mouradov, W Wasenang, IY Luk, CM Scott, DS Williams, YH Yeung, T Limpaiboon, GF Iatropoulos, LJ Jenkins, CM Reehorst, F Chionh, M Nikfarjam, D Croagh, AS Dhillon, AJ Weickhardt, T Muramatsu, Y Saito, NC Tebbutt, OM Sieber Show all
Iscience | CELL PRESS | Published : 2019
Abstract
Biological Sciences; Genetics; Genomics; Cancer
Grants
Awarded by Hellenic Society of Medical Oncology
Funding Acknowledgements
This project was supported by the Victorian Cancer Agency (TRP13083), NHMRC Senior Research Fellowships to JMM (1046092) and OMS (1126119), and the Operational Infrastructure Support Program, Victorian Government, Australia. DL, LJ, and GI were supported by La Trobe University Australian Postgraduate Awards, and DL a scholarship from the Pancare Foundation, and GI a scholarship from the Hellenic Society of Medical Oncology. FC was supported by NHMRC Medical Postgraduate Scholarship (1017737), and YHY supported by a Fellowship from the ANZ Trustees Foundation (Brian Smith Endowment). We thank AGIOS Pharmaceuticals for measurement of 2-HG levels. The results shown here are in part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.